Familial Mediterranean fever: New phenotypes

Autoimmunity Reviews

Volumn 12, Issue 1, 2012, Pages 31-37

  Soriano, Alessandra ^a   Manna, Raffaele ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Familial Mediterranean fever; Genotypes; Mediterranean fever gene; Phenotypes

Indexed keywords

C REACTIVE PROTEIN; COLCHICINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ABDOMINAL PAIN; AMYLOIDOSIS; ARMENIA; ARTHRITIS; DISEASE CLASSIFICATION; DIZZINESS; ENVIRONMENTAL FACTOR; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; ETHNIC GROUP; ETHNICITY; EXON; FAMILIAL MEDITERRANEAN FEVER; FAMILY HISTORY; FEVER; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GERMANY; HOMOZYGOSITY; INCREASED APPETITE; INFLAMMATION; IRRITABILITY; ONSET AGE; PENETRANCE; PREDICTIVE VALUE; RECURRENT FEVER; REVIEW; SENSITIVITY AND SPECIFICITY; THORAX PAIN; TURKEY (REPUBLIC); UNITED STATES;

CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; GENES, RECESSIVE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; PENETRANCE;

EID: 84866865074     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.07.019     Document Type: Review

References (79)

1. Ben-Chetrit E., Levy M. Familial Mediterranean fever. Lancet 1998, 351:659-664.
2. Konstantopoulos K., Kanta A., Deltas C., Atamian V., Mavrogianni D., Tzioufas A.G., et al. Familial Mediterranean fever associated pyrin mutations in Greece. Ann Rheum Dis 2003, 62:479-481.
3. La Regina M., Nucera G., Diaco M., Procopio A., Gasbarrini G., Notarnicola C., et al. Familial Mediterranean fever is no longer a rare disease in Italy. Eur J Hum Genet 2004, 12:85-86.
4. The French FMF Consortium A candidate gene for familial Mediterranean fever. Nat Genet 1997, 17:25-31.
5. The International FMF Consortium Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997, 90:797-807.
6. Centola M., Wood G., Frucht D.M., Galon J., Aringer M., Farrell C., et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000, 95:3223-3231.
7. Diaz A., Hu C., Kastner D.L., Schaner P., Reginato A.M., Richards N., et al. Lipopolysaccharide-induced expression of multiple alternatively spliced MEFV transcripts in human synovial fibroblasts: a prominent splice isoform lacks the C-terminal domain that is highly mutated in familial Mediterranean fever. Arthritis Rheum 2004, 50:3679-3689.
8. Milhavet F., Cuisset L., Hoffman H.M., Slim R., El-Shanti H., Aksentijevich I., et al. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat 2008, 29:803-808.
9. Brik R., Shinawi M., Kepten I., Berant M., Gershoni-Baruch R. Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 1999, 103:70-73.
10. Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 2001, 9:473-483.
11. Yilmaz E., Ozen S., Balci B., Duzova A., Topaloglu R., Besbas N., et al. Mutation frequency of Familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 2001, 9:553-555.
12. Majeed H.A., El-Shanti H., Al-Khateeb M.S., Rabaiha Z.A. Genotype\phenotype correlations in Arab patients with familial Mediterranean fever. Semin Arthritis Rheum 2002, 31:371-376.
13. Gershoni-Baruch R., Brik R., Shinawi M., Livneh A. The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 2002, 10:145-149.
14. Livneh A., Langevitz P., Zemer D., Zaks N., Kees S., Lidar T., et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997, 40:1879-1885.
15. Tunçbilek E., Koç I. Consanguineous marriage in Turkey and its impact on fertility and mortality. Ann Hum Genet 1994, 58:321-329.
16. Yalçinkaya F., Ozen S., Ozçakar Z.B., Aktay N., Cakar N., Duzova A., et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford) 2009, 48:395-398.
17. Kondi A., Hentgen V., Piram M., Letierce A., Guillame-Czitrom S., Koné-Paut I. Validation of the new pediatric criteria for the diagnosis of familial Mediterranean fever: data from a mixed population of 100 children from the French reference centre for auto-inflammatory disorders. Rheumatology (Oxford) 2010, 49:2200-2203.
18. Ozçakar Z.B., Yalçinkaya F., Cakar N., Acar B., Bilgiç A.E., Uncu N., et al. Application of the new pediatric criteria and Tel Hashomer criteria in heterozygous patients with clinical features of FMF. Eur J Pediatr 2011, 170:1055-1057.
19. Balbir-Gurman A., Nahir A.M., Braun-Moscovici Y. Vasculitis in siblings with familial Mediterranean fever: a report of three cases and review of the literature. Clin Rheumatol 2007, 26:1183-1185.
20. Ozdogan H., Arisoy N., Kasapçapur O., Sever L., Calişkan S., Tuzuner N., et al. Vasculitis in familial Mediterranean fever. J Rheumatol 1997, 24:323-327.
21. Ben-Zvi I., Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol 2010, 7:105-112.
22. Gershoni-Baruch R., Brik R., Lidar M., Shinawi M., Livneh A. Male sex coupled with articular manifestations cause a 4-fold increase in susceptibility to amyloidosis in patients with familial Mediterranean fever homozygous for the M694V-MEFV mutation. J Rheumatol 2003, 30:308-312.
23. Gershoni-Baruch R., Brik R., Zacks N., Shinawi M., Lidar M., Livneh A. The contribution of genotypes at the MEFV and SSA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 2003, 48:1149-1155.
24. Stoffman N., Magal N. Higher than expected carrier rates for FMF in various Jewish ethnic groups. Eur J Hum Genet 2000, 8:307-310.
25. Livneh A., Langevitz P., Shinar Y., Zaks N., Kastner D.L., Pras M., et al. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid 1999, 6:1-6.
26. Ben-Chetrit E., Backenroth R. Amyloidosis induced, end-stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene. Ann Rheum Dis 2001, 60:146-149.
27. Balci B., Tinaztepe K., Yilmaz E., Guçer S., Ozen S., Topaloǧlu R., et al. MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: a retrospective clinico-pathological and molecular study. Nephrol Dial Transplant 2002, 17:1921-1923.
28. Yalçinkaya F., Akar N., Misirlioglu M. Familial Mediterranean fever amyloidosis and the Val1726Ala mutation. N Eng J Med 1998, 338:993-994.
29. Pras M. Familial Mediterranean fever: from the clinical syndrome to the cloning of the pyrin gene. Scand J Rheumatol 1998, 27:92-97.
30. Cronstein B.N., Terkeltaub R. The inflammatory process of gout and its treatment. Arthritis Res Ther 2006, 8(Suppl. 1):S3.
31. Nuki G. Colchicine: a critical appraisal of its mechanism of action and efficacy in crystal-induced inflammation. Curr Rheumatol Rep 2008, 10:218-227.
32. Ben-Chetrit E., Bergmann S., Sood R. Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases: a possible new outlook through microarray analysis. Rheumatology (Oxford) 2006, 45:274-282.
33. Cerquaglia C., Diaco M., Nucera G., La Regina M., Montalto M., Manna R. Pharmacological and clinical basis of treatment of familial Mediterranean fever (FMF) with colchicine or analogues: an update. Curr Drug Targets Inflamm Allergy 2005, 4:117-124.
34. Camus D., Shinar Y., Aamar S., Langevitz P., Ben-Zvi I., Livneh A., et al. 'Silent' carriage of two familial Mediterranean fever gene mutations in large families with only a single identified patient. Clin Genet Oct. 14 2011, x [Epub ahead of print]. 10.1111/j.1399-0004.2011.01785.
35. Ben-Chetrit E., Ben-Chetrit A. Familial Mediterranean fever and menstruation. BJOG 2001, 108:403-407.
36. Lidar M., Yaqubov M., Zaks N., Ben-Horin S., Langevitz P., Livneh A. The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. J Rheumatol 2006, 33:1089-1092.
37. Manna R., Cerquaglia C., Curigliano V., Fonnesu C., Giovinale M., Verrecchia E., et al. Clinical features of familial Mediterranean fever: an Italian overview. Eur Rev Med Pharmacol Sci 2009, 13(Suppl. 1):51-53.
38. Shohat M., Halpern G.J. Familial Mediterranean fever - a review. Genet Med 2011, 13:487-498.
39. Lidar M., Livneh A. Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med 2007, 65:318-324.
40. Sneh E., Pras M., Michaeli D., Shanin N., Gafni J. Protracted arthritis in familial Mediterranean fever. Rheumatol Rehabil 1977, 16:102-106.
41. Langevitz P., Livneh A., Zemer D., Shemer J., Pras M. Seronegative spondiloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum 1997, 27:67-72.
42. Lidar M., Kedem R., Mor A., Levartovsky D., Langevitz P., Livneh A. Arthritis as the sole episodic manifestation of familial Mediterranean fever. J Rheumatol 2005, 32:859-862.
43. Ertekin V., Selimoglu M.A., Pirim I. Familial Mediterranean fever in a childhood population in eastern Turkey. Pediatr Int 2005, 47:640-644.
44. Blum A., Gafni J., Sodar E., Shibolet S., Heller H. Amyloidosis, the sole manifestation of familial Mediterranean fever: further evidence for its genetic nature. Ann Inter Med 1962, 57:795-799.
45. Zemer D., Livneh A., Pras M., Sohar E. Familial Mediterranean fever in the colchicine era: the fate of a family. Am J Med Genet 1993, 43:340-344.
46. Hurwich B.J., Schwartz J., Goldfarb S. Record survival of siblings with familial Mediterranean fever, phenotype 1 and 2. Arch Intern Med 1970, 125:308-311.
47. Koçak H., Beşbaş N., Saatçi U., Bakkaloǧlu A. Amyloidosis in children with familial Mediterranean fever. Turk J Pediatr 1989, 31:281-287.
48. Saatçi U., Ozen S., Ozdemir S., Bakkaloglu A., Besbas N., Topaloglu R., et al. Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 1997, 156:619-623.
49. Yazici H., Ozdogan H. FMF in Turkey. Proceedings of the First International Conference on Familial Mediterranean fever (Jerusalem,1997) Tel Aviv: Freund 1997, 66-71. E. Sohar, J. Gafni, M. Pras (Eds.).
50. Livneh A. Amyloidosis of familial Mediterranean fever (FMF) - insights to FMF phenotype II. Harefuah 2006, 145:743-745. 782.
51. Kogan A., Shinar Y., Lidar M., Revivo A., Langevitz P., Padeh S., et al. Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet 2001, 102:272-276.
52. Marek-Yagel D., Berkun Y., Padeh S., Abu A., Reznik-Wolf H., Livneh A., et al. Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum 2009, 60:1862-1866.
53. Tchernitchko D., Moutereay S., Legendre M., Delahaye A., Cazeneuve C., Lacombe C., et al. MEFV analysis is of particularly weak diagnostic value for recurrent fever in western European Caucasian patients. Arthritis Rheum 2005, 52:3603-3605.
54. Bernot A., da Silva C., Petit J.L., Cruaud C., Caloustian C., Castet V., et al. Non founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet 1998, 7:1317-1325.
55. Padeh S., Shinar Y., Pras E., Zemer D., Langevitz P., Pras M., et al. Clinical and diagnostic value of genetic testing in 216 Israeli children with familial Mediterranean fever. J Rheumatol 2003, 30:185-190.
56. Federici L., Rittore-Domingo C., Kone-Paut I., Jorgensen C., Rodiere M., Le Quellec A., et al. A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients. Ann Rheum Dis 2006, 65:1427-1432.
57. Atagunduz P., Ergun T., Direskeneli H. MEFV mutations are increased in Behçet's disease and are associated with vascular involvement. Clin Exp Rheumatol 2003, 21(Suppl. 30):S35-S37.
58. Livneh A., Aksentijevich I., Langevitz P., Torosyan Y., G-Shoham N., Shinar Y., et al. A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet disease (FMF-BD). Eur J Hum Genet 2001, 9:191-196.
59. Akkoc N., Gul A. Familial Mediterranean fever and seronegative arthritis. Curr Rheumatol Rep 2011, 13:388-394.
60. Cosan F., Ustek D., Oku B., Duymaz-Tozkir J., Cakiris A., Abaci N., et al. Association of familial Mediterranean fever-related MEFV variations with ankylosing spondilytis. Arthritis Rheum 2010, 62:3232-3236.
61. Rabinovich E., Livneh A., Langevitz P., Brezniak N., Shinar E., Pras M., et al. Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis 2005, 64:1009-1014.
62. Yalçinkaya F., Tekin M., Cakar N., Akar E., Akar N., Tümer N. Familial Mediterranean fever and systemic amyloidosis in untreated Turkish patients. QJM 2000, 93:681-684.
63. Konè-Paut I., Dubuc M., Sportouch J., Minodier P., Garnier J.M., Touitou I. Phenotype/genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features. Rheumatology (Oxford) 2000, 39:1275-1279.
64. Shinar Y., Livneh A., Langevitz P., Zaks N., Aksentijevich I., Koziol D.E., et al. Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol 2000, 27:1703-1707.
65. Kutlay S., Sengul S., Keven K., Erturk S., Erbay B. Two sisters with familial Mediterranean fever: lack of correlation between genotype and phenotype?. J Nephrol 2006, 19:104-107.
66. Ben-Chetrit E., Lerer I., Malamud E., Domingo C., Abeliovich D. The E148Q mutation in the MEFV gene: is it a disease-causing mutation or a sequence variant?. Hum Mutat 2000, 15:385-386.
67. Tchernitchko D., Legendre M., Cazeneuve C., Delahaye A., Neil F., Amselem S. The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever. Hum Mutat 2003, 22:339-340.
68. Marek-Yagel D., Bar-Joseph I., Pras E., Berkun Y. Is E148Q a benign polymorphism or a disease-causing mutation?. J Rheumatol 2009, 36:2372.
69. Bakkaloglu A., Duzova A., Ozen S., Balci B., Besbas N., Topaloglu R., et al. Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial Mediterranean fever in the Turkish population. J Rheumatol 2004, 31:1139-1142.
70. Cazeneuve C., Ajrapetyan H., Papin S., Roudot-Thoraval F., Geneviève D., Mndjoyan E., et al. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 2000, 67:1136-1143.
71. Ozen S., Berdeli A., Turel B., Kutlay S., Yalçincaya F., Arici M., et al. Arg753Gln TLR-2 polymorphism in familial Mediterranean fever: linking the environment to the phenotype in a monogenic inflammatory disease. J Rheumatol 2006, 33:2498-2500.
72. Touitou I., Picot M.C., Domingo C., Notarnicola C., Cattan D., Demaille J., et al. The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum 2001, 44:163-169.
73. Schwabe A.D., Peters R.S. Familial Mediterranean fever in Armenians. Analysis of 100 cases. Medicine (Baltimore) 1974, 53:453-462.
74. Touitou I., Sarkisian T., Medlej-Hashim M., Tunca M., Livneh A., Cattan D., et al. International study group for phenotype-genotype correlation in familial Mediterranean fever. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 2007, 56:1706-1712.
75. Ozen S., Aktay N., Lainka E., Duzova A., Bakkaloglu A., Kallinich T. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis 2009, 68:246-248.
76. Sackesen C., Bakkaloglu A., Sekerel B., Ozaltin F., Besbas N., Yilmaz E., et al. Decreased prevalence of atopy in paediatric patients with familial Mediterranean fever. Ann Rheum Dis 2004, 63:187-190.
77. Akar S., Soyturk M., Onen F., Tunca M. The relations between attacks and menstrual periods and pregnancies of familial Mediterranean fever patients. Rheumatol Int 2006, 26:676-679.
78. Onen F. Familial Mediterranean fever. Rheumatol Int 2006, 26:489-496.
79. Ben-Zvi I., Brandt B., Berkun Y., Lidar M., Livneh A. The relative contribution of environmental and genetic factors to phenotypic variation in familial Mediterranean fever. Gene 2012, 491:260-263.